163 related articles for article (PubMed ID: 27056614)
21. Experimental models of Parkinson's disease: insights from many models.
Tolwani RJ; Jakowec MW; Petzinger GM; Green S; Waggie K
Lab Anim Sci; 1999 Aug; 49(4):363-71. PubMed ID: 10480640
[TBL] [Abstract][Full Text] [Related]
22. Depletion of AADC activity in caudate nucleus and putamen of Parkinson's disease patients; implications for ongoing AAV2-AADC gene therapy trial.
Ciesielska A; Samaranch L; San Sebastian W; Dickson DW; Goldman S; Forsayeth J; Bankiewicz KS
PLoS One; 2017; 12(2):e0169965. PubMed ID: 28166239
[TBL] [Abstract][Full Text] [Related]
23. Characterization and survival of long-term implants of human retinal pigment epithelial cells attached to gelatin microcarriers in a model of Parkinson disease.
Flores J; Cepeda IL; Cornfeldt ML; O'Kusky JR; Doudet DJ
J Neuropathol Exp Neurol; 2007 Jul; 66(7):585-96. PubMed ID: 17620984
[TBL] [Abstract][Full Text] [Related]
24. Differentiation of adult human retinal pigment epithelial cells into dopaminergic-like cells in vitro and in the recipient monkey brain.
Li S; Zhang H; Wang A; Liu Y; Liu H; Yue F; Abulaiti X; Zhang C; Li L
Mol Med; 2019 Mar; 25(1):9. PubMed ID: 30922214
[TBL] [Abstract][Full Text] [Related]
25. Convection-enhanced selective excitotoxic ablation of the neurons of the globus pallidus internus for treatment of parkinsonism in nonhuman primates.
Lonser RR; Corthésy ME; Morrison PF; Gogate N; Oldfield EH
J Neurosurg; 1999 Aug; 91(2):294-302. PubMed ID: 10433318
[TBL] [Abstract][Full Text] [Related]
26. Metabolic brain networks associated with cognitive function in Parkinson's disease.
Huang C; Mattis P; Tang C; Perrine K; Carbon M; Eidelberg D
Neuroimage; 2007 Jan; 34(2):714-23. PubMed ID: 17113310
[TBL] [Abstract][Full Text] [Related]
27. Spectral guided sparse inverse covariance estimation of metabolic networks in Parkinson's disease.
Spetsieris PG; Eidelberg D
Neuroimage; 2021 Feb; 226():117568. PubMed ID: 33246128
[TBL] [Abstract][Full Text] [Related]
28. Transplantation of human retinal pigment epithelium cells in the treatment for Parkinson disease.
Yin F; Tian ZM; Liu S; Zhao QJ; Wang RM; Shen L; Wieman J; Yan Y
CNS Neurosci Ther; 2012 Dec; 18(12):1012-20. PubMed ID: 23190934
[TBL] [Abstract][Full Text] [Related]
29. Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism.
Feigin A; Antonini A; Fukuda M; De Notaris R; Benti R; Pezzoli G; Mentis MJ; Moeller JR; Eidelberg D
Mov Disord; 2002 Nov; 17(6):1265-70. PubMed ID: 12465066
[TBL] [Abstract][Full Text] [Related]
30. Corticostriatal covariance patterns of 6-[18F]fluoro-L-dopa and [18F]fluorodeoxyglucose PET in Parkinson's disease.
Kaasinen V; Maguire RP; Hundemer HP; Leenders KL
J Neurol; 2006 Mar; 253(3):340-8. PubMed ID: 16222426
[TBL] [Abstract][Full Text] [Related]
31. Parkinson's disease-related perfusion and glucose metabolic brain patterns identified with PCASL-MRI and FDG-PET imaging.
Teune LK; Renken RJ; de Jong BM; Willemsen AT; van Osch MJ; Roerdink JB; Dierckx RA; Leenders KL
Neuroimage Clin; 2014; 5():240-4. PubMed ID: 25068113
[TBL] [Abstract][Full Text] [Related]
32. Longitudinal behavioral and 6-[18F]fluoro-L-DOPA-PET assessment in MPTP-hemiparkinsonian monkeys.
Melega WP; Raleigh MJ; Stout DB; DeSalles AA; Cherry SR; Blurton-Jones M; Morton GG; Huang SC; Phelps ME
Exp Neurol; 1996 Oct; 141(2):318-29. PubMed ID: 8812167
[TBL] [Abstract][Full Text] [Related]
33. Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model.
Kikuchi T; Morizane A; Doi D; Magotani H; Onoe H; Hayashi T; Mizuma H; Takara S; Takahashi R; Inoue H; Morita S; Yamamoto M; Okita K; Nakagawa M; Parmar M; Takahashi J
Nature; 2017 Aug; 548(7669):592-596. PubMed ID: 28858313
[TBL] [Abstract][Full Text] [Related]
34. Postmortem brain fatty acid profile of levodopa-treated Parkinson disease patients and parkinsonian monkeys.
Julien C; Berthiaume L; Hadj-Tahar A; Rajput AH; Bédard PJ; Di Paolo T; Julien P; Calon F
Neurochem Int; 2006 Apr; 48(5):404-14. PubMed ID: 16442670
[TBL] [Abstract][Full Text] [Related]
35. Quantification of Parkinson's disease-related network expression with ECD SPECT.
Eckert T; Van Laere K; Tang C; Lewis DE; Edwards C; Santens P; Eidelberg D
Eur J Nucl Med Mol Imaging; 2007 Apr; 34(4):496-501. PubMed ID: 17096095
[TBL] [Abstract][Full Text] [Related]
36. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
Jenner P; Marsden CD
J Neural Transm Suppl; 1986; 20():11-39. PubMed ID: 3091760
[TBL] [Abstract][Full Text] [Related]
37. Decreased Rhes mRNA levels in the brain of patients with Parkinson's disease and MPTP-treated macaques.
Napolitano F; Booth Warren E; Migliarini S; Punzo D; Errico F; Li Q; Thiolat ML; Vescovi AL; Calabresi P; Bezard E; Morelli M; Konradi C; Pasqualetti M; Usiello A
PLoS One; 2017; 12(7):e0181677. PubMed ID: 28742811
[TBL] [Abstract][Full Text] [Related]
38. Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.
Appel L; Jonasson M; Danfors T; Nyholm D; Askmark H; Lubberink M; Sörensen J
J Nucl Med; 2015 Feb; 56(2):234-42. PubMed ID: 25593112
[TBL] [Abstract][Full Text] [Related]
39. Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease.
Feigin A; Kaplitt MG; Tang C; Lin T; Mattis P; Dhawan V; During MJ; Eidelberg D
Proc Natl Acad Sci U S A; 2007 Dec; 104(49):19559-64. PubMed ID: 18042721
[TBL] [Abstract][Full Text] [Related]
40. Changes in glutamate receptors in dyskinetic parkinsonian monkeys after unilateral subthalamotomy.
Jourdain VA; Morin N; Grégoire L; Morissette M; Di Paolo T
J Neurosurg; 2015 Dec; 123(6):1383-93. PubMed ID: 25932606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
